Study title: Randomized, double-blind, 3-period crossover, exercise challenge study of 50 mcg and 100 mcg HFA-Beclometasone Dipropionate Autohaler and HFA-Placebo dosed once a day in children with asthma*
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: please see report | |||||
MAH holders: please see report | |||||
Assessment: | |||||
Active substance: BECLAMETHASONE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: 1389-BRON | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |